You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymalfasin

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and

Not yet recruiting
  • Colorectal Neoplasms
  • Thymalfasin
  • Beijing, Xicheng Dis, China
    Beijing Friendship Hospital, Capital medical University
Sep 5, 2023

Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Beijing, China
  • +1 more
Sep 21, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Thymalfasin
  • +3 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023

COVID-19 Trial in Kansas City (Thymalfasin)

Recruiting
  • COVID-19
  • Thymalfasin
  • Kansas City, Kansas
    Clinical Research Consultants
Mar 29, 2022

Covid19 Trial in Providence (Thymalfasin)

Recruiting
  • Covid19
  • Thymalfasin
  • Providence, Rhode Island
    The Miriam Hospital
Sep 14, 2021

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

HIV-1-infection Trial in Shanghai (Zadaxin)

Recruiting
  • HIV-1-infection
  • Shanghai, Shanghai, China
    Fudan University
Sep 5, 2021

Stage II Colorectal Cancer, Stage III Colorectal Cancer Trial in Shanghai (Thymosin Alpha1)

Recruiting
  • Stage II Colorectal Cancer
  • Stage III Colorectal Cancer
  • Thymosin Alpha1
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 7, 2021

Colorectal Cancer, Metastatic Colorectal Cancer, Thymalfasin Trial (Radiation therapy, Thymalfasin)

Withdrawn
  • Colorectal Cancer
  • +2 more
  • Radiation therapy
  • Thymalfasin
  • (no location specified)
Jun 18, 2019

Small Cell Lung Cancer, Radiotherapy, Thymalfasin Trial (Radiotherapy, Thymalfasin)

Withdrawn
  • Small Cell Lung Cancer
  • +2 more
  • Radiotherapy
  • Thymalfasin
  • (no location specified)
Mar 19, 2019

NSCLC, Metastatic NSCLC, Radiotherapy Trial (Radiotherapy, Thymalfasin)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • Radiotherapy
  • Thymalfasin
  • (no location specified)
Mar 23, 2019

Rheumatic Heart Disease, Cardiopulmonary Bypass, Immunotherapy Trial in Nanjing (Thymosin Alpha1, Blank Control)

Recruiting
  • Rheumatic Heart Disease
  • +2 more
  • Thymosin Alpha1
  • Blank Control
  • Nanjing, Jiangsu, China
    The first affiliated hospital of nanjing medical university
Aug 3, 2022

Acute Aortic Syndrome, Aortic Dissectio Trial in Nanjing, Beijing (Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic

Recruiting
  • Acute Aortic Syndrome
  • Aortic Dissectio
  • Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic Acid-28D-L-Alanine-28E-L-Proline-28F-L-Alanine-28G-L-Asparagine-
  • Blank control
  • Nanjing, Jiangsu, China
  • +2 more
Sep 25, 2022

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Sepsis Trial in Guangzhou (thymosin alpha 1, Placebo)

Completed
  • Sepsis
  • thymosin alpha 1
  • Placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Apr 2, 2019

Long-term Effects of Thymosin Alpha 1 Treatment Trial (Thymosin Alpha1)

Not yet recruiting
  • Long-term Effects of Thymosin Alpha 1 Treatment
  • Thymosin Alpha1
  • (no location specified)
May 24, 2021

Liver Failure Trial in Guangzhou (Thymosin-a1)

Completed
  • Liver Failure
  • Guangzhou, Guangdong, China
    Third Affliated Hospital of Sun Yat-sen University
Aug 8, 2021

Pancreatitis, Acute Necrotizing Trial in Nanjing (Thymosin Alpha 1, normal saline)

Completed
  • Pancreatitis, Acute Necrotizing
  • Thymosin Alpha 1
  • normal saline
  • Nanjing, Jiangsu, China
  • +1 more
Apr 1, 2021

NSCLC Trial in Guangzhou (Concurrent chemo, split-course radiotherapy, thymosin alpha 1)

Completed
  • Non-small Cell Lung Cancer
  • Concurrent chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Dec 30, 2021

Osteoporotic Pain Trial in Shanghai (Thymosin Alpha1)

Unknown status
  • Osteoporotic Pain
  • Thymosin Alpha1
  • Shanghai, Shanghai, China
    Diansan Su
Aug 24, 2020

Acute Respiratory Distress Syndrome Trial in China (device, behavioral, drug, other, biological, combination product, genetic)

Recruiting
  • Acute Respiratory Distress Syndrome
  • protective ventilation
  • +13 more
  • Beijing, China
  • +10 more
Dec 13, 2022

Chronic Hepatitis b Trial in Shanghai (Thymosin Alpha1, Entecavir)

Unknown status
  • Chronic Hepatitis b
  • Shanghai, Shanghai, China
    Huashan Hospital of Fudan University
Feb 22, 2018

Esophageal Cancer, Metastatic Esophageal Cancer, Stereotactic Body Radiation Therapy Trial in Hangzhou (Stereotactic Body

Unknown status
  • Esophageal Cancer
  • +3 more
  • Stereotactic Body Radiation Therapy
  • Thymalfasin
  • Hangzhou, Zhejiang, China
    Hangzhou Cancer Hospital
Nov 26, 2017

2019 Novel Coronavirus Infection Trial in Shiyan (recombinant human interferon Alpha-1b, thymosin alpha 1)

Unknown status
  • 2019 Novel Coronavirus Infection
  • recombinant human interferon Alpha-1b
  • thymosin alpha 1
  • Shiyan, Hubei, China
    Taihe Hospital
Mar 30, 2020

Metastatic Cancer Trial in Hangzhou (Non Chemotherapy, Chemotherapy and target therapy, Chinese herb medicine)

Unknown status
  • Metastatic Cancer
  • Non Chemotherapy
  • +2 more
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, affiliated with Zhejiang University S
Feb 12, 2019